反应详情

To a suspension of 0.05 g (0.12 mMol) morpholine-4-carboxylic acid (4-methoxy-7-piperidin-4-yl-benzothiazol-2-yl)-amide hydrochloride (1:1) in 3 ml THF were added 0.019 ml triethyl amine. At 0° C. 0.011 ml (0.13 mMol) chloro formic acid methyl ester was added dropwise and stirred for 1 h. Then a mixture of 5 ml sat. aqueous sodium bicarbonate and 10 ml water were added. This was extracted three times with 15 ml ethyl acetate, the combined organic phase were dried over sodium sulfate and evaporated to dryness in vacuo. One obtained 0.037 g (70%) 4-{4-methoxy-2-[(morpholine-4-carbonyl)-amino]-benzothiazol-7-yl}-piperidine-1-carboxylic acid methyl ester as a white solid. F.p.: 179-185° C.

1. customAt 0° C
2. additionwere added
3. extractionThis was extracted three times with 15 ml ethyl acetate
4. dry with materialthe combined organic phase were dried over sodium sulfate
5. customevaporated to dryness in vacuo